Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective

Publisher: Karger

E-ISSN: 1421-9891|23|1|7-18

ISSN: 1022-6877

Source: European Addiction Research, Vol.23, Iss.1, 2016-10, pp. : 7-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content